Xerox Reveals Suite of Production Print Innovations to Address Industry Demand
Xerox (NYSE: XRX) announced a suite of production print innovations including new presses, technology enhancements for existing printers as well as artificial intelligence and automation features that aid speed and productivity.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201118006025/en/
Innovation champion, Bindi Karia hosted the Xerox Production Innovation Reveal (Photo: Business Wire)
At a virtual event attended by partners and clients around the world, Xerox unveiled the following innovations:
- A Color Accelerator module for Baltoro, expanding inkjet applications and adding ink-saving automation
- Addition of fluorescent pink to the Iridesse Production Press, enhancing its metallics, white and clear color palette
- Three new printers capable of higher volumes, more media and extended color options in the VersaLink and Versant family
- Two Xerox Nuvera print speed upgrades that best competition
- AI-enabled media manager software that enables high-quality images with minimal set-up and staff time
- Automated workflow updates to seamlessly print embellishments with FreeFlow Core 6.0
As the leader in the production color market, Xerox is committed to helping customers expand their business, enhance productivity with new technology and protect their existing investments with new tools and features.
Digital print enhancements increase profitability, delivering higher margins and allowing print customers to expand into new areas. According to Keypoint Intelligence, digital print enhancement is expected to generate $25 billion a year and can increase a printers’ profit by 50 to 400 percent. By making it easier, customizable and faster to produce these pages, Xerox technology provides multiple entry options for customers to expand their business and increase profit.
“Print enhancement is the fastest-growing segment in print and Xerox offers the broadest set of solutions to help clients expand their business here,” said Tracey Koziol, senior vice president of Global Offerings, Xerox. “The new technology and features we are launching expand the capabilities and profit potential of existing devices while introducing new presses that respond to demand for higher volume and extended media and color palettes. There’s a reason Xerox remains top in the production print market.”
Xerox Color Accelerator for Baltoro
The Xerox Baltoro™ High Fusion Inkjet Press platform, No. 1 in the B3 cut-sheet inkjet market, now has a field-upgradable module that expands its range. The Xerox Color Accelerator for Xerox Baltoro HF Inkjet Press enables increased print quality, expanded media options and automation to make inkjet printing viable for lucrative applications such as direct mail, postcards and catalogs. With intelligent automation, Baltoro uses 50% less ink than competitor presses to purge inkjet heads, increasing uptime and productivity while delivering consistent, reliable quality.
Introduced last year, Baltoro is redefining the inkjet market. At a fraction of the size, weight and power consumption of competitor presses, Baltoro offers a lower total cost of ownership (TCO) while being the only scalable, customizable platform in its class.
Fluorescent Pink for Iridesse
Xerox has the broadest color capability and Beyond CMYK offerings across any portfolio. No one offers the range of colors, embellishments, mixed metallics, extended gamut, media options and single-pass digital enhancement technology as Xerox.
The Xerox Iridesse® Production Press is adding fluorescent pink specialty dry ink option to its existing Beyond CMYK palette of gold, silver, white and clear. These embellishments allow print providers to differentiate and offer their clients eye-popping designs and enhancements.
New VersaLink Graphic Arts Printer
The newest addition to our VersaLink family is the Xerox VersaLink® C8000W, the most affordable entry point into the embellishment market. Using white toner as a base on dark and colored stocks, its cyan, magenta and yellow toners make images pop for applications such as menus, envelopes, window clings, decals and labels. A small footprint device, the C8000W offers clarity and quality that stands out over the typical four-color print.
Two New Versants
Xerox is expanding its Versant family of presses with two new machines that support wider media options and add automation features that reduce staffing needs and set-up time.
The Xerox Versant® 280 Press , a mid-production press, provides added value with thicker stock media options (400 GSM) for applications such as business cards. With the All Stocks at Rated Speed (ASRS) option, the Versant 280 is faster than any competitor in printing heavy stocks. Customers can print a million specialty colors using an Adaptive CMYK+ kit that leverages white, gold, silver, clear and fluorescents, unique to Xerox in this class of products.
The Xerox Versant 4100 Press , handles higher volumes and heavier production loads than the Versant 280, bringing more jobs in-house by reducing set-up time and printing on more media types than any competitor press. The 4100 also handles thicker paper stocks, up to 400 GSM. Automated stock management saves time and reduces human error.
Faster Xerox Nuveras
The Xerox Nuvera® family is built for high production environments with our customers making more than 35 billion prints last year. The Xerox Nuvera 157 MX Production System and Xerox Nuvera MX Perfecting Production System monochrome production presses have upgraded the magnetic ink character recognition (MICR) print speeds to exceed any competitive press. MICR, the line of numbers that allows certain computers to read and process information, is key for processing bank, payroll and government checks with tested and trusted Xerox Nuvera security.
AI-enabled media manager software. PredictPrint Media Manager Software is included with the new Versant 4100 and can be added to Iridesse. By using artificial intelligence, the software automatically identifies the media being used and provides the correct press settings. Users simply scan a barcode, place the paper in a tray, and use the set-up wizard to walk through optimizing the system for that application.
FreeFlow® Core 6.0 automates the process of preparing a file to print and now includes the application of Beyond CMYK enhancements. FreeFlow Core uses pre-built workflows to seamlessly apply embellishments such as gold, silver, white, clear and fluorescents without changing the source file.
“These new products and features represent the sweet spot of technology, where end-to-end solutions support our customers need to differentiate and expand their businesses in any economic environment,” said Marybeth Gilbert, vice president and general manager, Production Business, Xerox. “Our customers know they can count on Xerox innovation in response to their business needs.”
- Xerox Color Accelerator for Xerox Baltoro HF Inkjet Press - Current Baltoro customers will be able to order Color Accelerator beginning in 2021. New Baltoro customers will be able to place orders for Color Accelerator starting December 15 with installs expected to begin in Q1 2021.
- The VersaLink C8000W is available immediately worldwide.
- The Xerox Nuvera 157 MX Production System and Xerox Nuvera 314 MX Perfecting Production System - order taking and availability December 1, 2020.
- The Xerox Versant 280 is available now based upon channel and geography.
- The Xerox Versant 4100 with PredictPrint Media Manager Software is available now based upon channel and geography.
- Iridesse pink specialty dry ink option and the PredictPrint Media Manager Software option are available for order taking December 1, 2020 and availability beginning March 1, 2021.
- The XLS Automatic Feeding Kit option for Iridesse is available immediately worldwide.
Xerox Holdings Corporation (NYSE: XRX) makes every day work better. We are a workplace technology company building and integrating software and hardware for enterprises large and small. As customers seek to manage information across digital and physical platforms, Xerox delivers a seamless, secure and sustainable experience. Whether inventing the copier, Ethernet, the laser printer or more, Xerox has long defined the modern work experience. Learn how that innovation continues at xerox.com.
Note: To receive RSS news feeds, visit https://www.news.xerox.com. For open commentary, industry perspectives and views, visit http://twitter.com/xerox, http://www.facebook.com/XeroxCorp, https://www.instagram.com/xerox/, http://www.linkedin.com/company/xerox, http://www.youtube.com/XeroxCorp.
Xerox®, Baltoro™, FreeFlow®, Iridesse®, VersaLink®, Versant® and Xerox Nuvera® are trademarks of Xerox in the United States and/or other countries.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Ipsen: ESMO 2021: Cabometyx® Demonstrates Sustained 78% Reduction in Risk of Disease Progression or Death in People Living With Uncommon Form of Thyroid Cancer18.9.2021 07:30:00 EEST | Press release
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced presentation of new analyses at the European Society for Medical Oncology (ESMO) Congress 2021 across different forms of cancer for people treated with Cabometyx® (cabozantinib). Of note, the final analysis of the pivotal Phase III COSMIC-311 trial (Abstract LBA67) will be presented, with Cabometyx demonstrating a clinically meaningful, sustained efficacy benefit versus placebo in people living with previously treated radioactive iodine-refractory differentiated thyroid cancer (RAI-R DTC). With a median follow-up of 10.1 months, Cabometyx continued to demonstrate superior median progression-free survival (mPFS) with a reduction in the risk of disease progression or death of 78% versus placebo (hazard ratio [HR]: 0.22, 96% confidence interval [CI]: 0.15-0.32; p<0.0001).1 This final analysis is consistent with data from the interim analysis, presented at the American Society of Clinical Oncology (ASCO) Annual Meeting 2021
Unifrax Hosts Groundbreaking Ceremony for SiFAB™ Manufacturing Line17.9.2021 21:46:00 EEST | Press release
Today, Unifrax, a leading manufacturer of high-performance specialty materials, held a ceremonial event celebrating its first large-scale SiFAB™ Silicon Fiber Anode Battery Technology manufacturing line, which is currently under construction at the company’s north central Indiana facility. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210917005495/en/ Unifrax team celebrates SiFAB groundbreaking at New Carlisle plant. (Photo: Business Wire) The event recognized Unifrax’s ongoing partnership with the State of Indiana and St. Joseph County, along with SiFAB’s continued progress. Unifrax executives, along with the SiFAB manufacturing team and local and state government officials, kicked off the ceremony at 10 a.m. EDT at the New Carlisle, IN plant, with remarks by John Dandolph, president and CEO, Unifrax. “Through the support of the State of Indiana and St. Joseph County, we have the ability to leverage our existing New Carli
Prince William announces 15 Finalists for inaugural year of the £50 million Earthshot Prize17.9.2021 20:01:00 EEST | Press release
The Earthshot Prize announces today its first-ever shortlist of 15 Finalists, each with a chance of winning £1million to support their innovative environmental solutions to the greatest challenges facing the planet. Prince William said: "Over half a century ago, President Kennedy’s ‘Moonshot’ programme united millions of people around the goal of reaching the moon. Inspired by this, The Earthshot Prize aims to mobilise collective action around our unique ability to innovate, problem solve and repair our planet. “I am honoured to introduce the 15 innovators, leaders, and visionaries who are the first ever Finalists for The Earthshot Prize. They are working with the urgency required in this decisive decade for life on Earth and will inspire all of us with their optimism in our ability to rise to the greatest challenges in human history.” Launched by Prince William and The Royal Foundation in October 2020, The Earthshot Prize is the most prestigious global environment prize in history. Li
Wipro Announces Co-innovation Space with Google Cloud17.9.2021 16:32:00 EEST | Press release
Wipro Limited (NYSE: WIT, BSE: 507685, NSE: WIPRO), a leading global information technology, consulting and business process services company, today announced the launch of the Wipro-Google Cloud Innovation Arena in Bangalore, India. This cloud collaboration space will provide in-house technical expertise, ensure seamless cloud adoption, and accelerate innovation to drive business transformation for customers. By combining the expertise and resources of Wipro FullStride Cloud Services and Google Cloud, this jointly developed innovation center will offer a unique combination of people, processes, and platforms that will collectively create a futuristic experience for customers globally. This state-of-the-art arena will showcase the talent, tools and best practices required to develop and deploy applications on Google Cloud. Jason Eichenholz, Senior Vice President, Global Head of Ecosystems & Partnerships, Wipro Limited said, “We are excited to strengthen our partnership with Google Clou
Zynga Announces ReVamp, the First Multiplayer Social Deception Game For Snapchat17.9.2021 16:00:00 EEST | Press release
Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, announced today that ReVamp, an upcoming multiplayer social deception game, will launch soon in select markets exclusively for Snapchat. The vampire-themed game will be the first social deception title on Snapchat, giving Snapchatters their first chance to sink their teeth into this popular genre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210917005012/en/ Zynga Announces ReVamp, the First Multiplayer Social Deception Game For Snapchat (Graphic: Business Wire) ReVamp is a real-time multiplayer imposter game where players aim to reveal who the vampire player is among their group of friends while they renovate the rooms of an old mansion. In the game, human players must complete renovation tasks, such as demolition and building, to improve their chances of survival while identifying and defeating the vampire during the voting phase. Vampire players mu
BeiGene Receives Positive CHMP Opinion for BRUKINSA® (Zanubrutinib) for the Treatment of Adults with Waldenström’s Macroglobulinemia17.9.2021 15:00:00 EEST | Press release
BeiGene (NASDAQ: BGNE; HKEX: 06160) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending approval of BRUKINSA (zanubrutinib) for the treatment of adult patients with Waldenström’s macroglobulinemia (WM) who have received at least one prior therapy or first-line treatment for patients unsuitable for chemo-immunotherapy. “Bruton’s tyrosine kinase (BTK) inhibitors have emerged as a promising treatment for WM, yet treatment discontinuation due to lack of response or side effects remains a concern,” said Prof. Christian Buske, Medical Director at the University Hospital Ulm, Germany, and a trial investigator of the ASPEN study. “The ASPEN trial demonstrated that BRUKINSA provided deep and durable responses and offered substantial improvements in safety and tolerability over standard therapy. Patients in Europe with WM may soon have a new treatment option that can offer improved outcomes.
Janssen Receives Positive CHMP Opinion for BYANNLI® (6-monthly Paliperidone Palmitate) for the Maintenance Treatment of Schizophrenia in Adults17.9.2021 13:50:00 EEST | Press release
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending the long-acting atypical antipsychotic therapy BYANNLI® (6-monthly paliperidone palmitate; PP6M) for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1-monthly paliperidone palmitate (PP1M)2 or 3-monthly paliperidone palmitate (PP3M).3 If approved by the European Commission, PP6M will provide the first twice-yearly treatment for adults living with schizophrenia and longest available dosing interval for an antipsychotic medication in the European Economic Area.1,4 “With only two injections per year, 6-monthly paliperidone palmitate has the potential to reduce the burden of taking medication frequently, giving eligible patients the opportunity to focus on other aspects of their life,” said Ludovic de Beaucoudrey, Ph.D., EMEA Therape
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom